News

Results of Retatrutide show promising outcomes for those wanting to loose weight and control their Type 2 diabetes...

Results of a late-stage trial show that Type 2 diabetes patients using Eli Lilly’s highly anticipated next-generation weight-loss drug Retatrutide experienced a significant reduction in blood-sugar levels and weight loss...

Researchers found taking weight loss jabs was linked to a lower risk of mental health problems, including a 44% decreased risk of worsening depression associated with Semaglutide, the well-known active ingredient within Ozempic, Rybelsus and Wegovy.

New research shows that weight-loss drugs could treat addiction to alcohol, cigarettes, gambling and drugs. Experts believe the way the GLP-1 and GIP blockbuster weight loss medications work on the brain’s reward pathway can help reduce cravings for many different substances, not just food. Mounjaro, a GLP-1 Receptor Agonist that helps aid weight loss Glucagon-like peptide-1 receptor agonists (GLP-1s), such as Wegovy, and glucose-dependent insulinotropic polypeptide (GIP) li

We've all heard of the 'golden dose' or the '5th dose' found when someone has used the 4 weeks worth of doses in the Mounjaro KwikPen. But now it looks like that extra fluid in the pen is about the vanish...

The "King Kong" of weight loss medications, Mounjaro (tirzepatide), is a dual GIP and GLP-1 receptor agonist licensed in the UK for treating type 2 diabetes mellitus and for weight loss. As with any medication affecting pancreatic function, questions have emerged regarding potential links between Mounjaro and pancreatic cancer. Current evidence from clinical trials and regulatory reviews does not establish a causal relationship between tirzepatide and pancreatic malignancy. L

The "King Kong" of weight loss medications, Mounjaro (tirzepatide), is a dual GIP and GLP-1 receptor agonist licensed in the UK for treating type 2 diabetes mellitus and for weight loss. As with any medication affecting pancreatic function, questions have emerged regarding potential links between Mounjaro and pancreatic cancer. Current evidence from clinical trials and regulatory reviews does not establish a causal relationship between tirzepatide and pancreatic malignancy. L

Researchers say daily calorie intake may be up to 10 times more influential than physical activity in weight gain.

You may have heard that Rybelsus is changing doses... RIP 3mg, 7mg & 14mg

A MAJOR review has pitted the big three blockbuster weight management jabs against each other – comparing weight lost and how long users were able to maintain it. There are several weight loss treatments now available in the UK via the NHS and private clinics Scientists compar ed tirzepatide – the active ingredient of Mounjaro – to semaglutide, which is in Wegovy and Ozempic, and liraglutide, that’s in Saxenda. he reviews – published in the gold-standard Cochrane Database of

You may have seen the news over the weekend regarding a UK woman who used "black market" weight loss medication at a local salon for £20 a jab. The drive for weight loss medications has created a boom in black market sales of medications.

The MHRA has raided & shut down a factory in the UK producing fake Mounjaro (Tirzepatide) and the yet-to-be-released Retatrutide.

MHRA take down illegal UK factory making Mounjaro (Tirzepatide) and Retatrutide.

The vast majority of patients on Mounjaro currently pay for it privately but some patients can get it on the NHS...

The vast majority of patients on Mounjaro currently pay for it privately but some patients can get it on the NHS...

Wegovy mimics the hormone GLP-1, acting on the brain to reduce appetite and slow digestion. Contrave (naltrexone/bupropion) affects brain reward and craving pathways, which can reduce emotional eating but doesn’t directly target satiety hormones. How Wegovy works Wegovy (semaglutide 2.4 mg weekly) is a GLP-1 receptor agonist. It mimics a natural gut hormone called GLP-1, which signals to the brain that you are full, slows down stomach emptying, and enhances insulin release wh

Nausea? Hair loss? Headaches Acid reflux? Sulphur burps? These can be some of the most common side effects when using weight loss medications such as Mounjaro and Wegovy. We can help.

Nausea? Hair loss? Headaches Acid reflux? Sulphur burps? These can be some of the most common side effects when using weight loss medications such as Mounjaro and Wegovy. We can help.

Since both contain semaglutide, their side-effect profiles are similar — most commonly nausea, vomiting, and diarrhoea. Wegovy uses a...

On the NHS, costs are set through commercial arrangements and are not always public, while in private practice the listed prices for...